Solomon, D <br/><br/>
The impact of MMX mesalazine on disease-specific health-related quality of life in ulcerative colitis patients.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  Jun 2012 
 - 1386-96 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2036 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2036.2012.05107.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Analysis of Variance<br/>Anti-Inflammatory Agents, Non-Steroidal--administration & dosage<br/>Clinical Trials as Topic<br/>Colitis, Ulcerative--drug therapy<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Male<br/>Mesalamine--administration & dosage<br/>Middle Aged<br/>Quality of Life<br/>Severity of Illness Index<br/>Surveys and Questionnaires<br/>Time Factors<br/>Treatment Outcome<br/>Young Adult